These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 11273729

  • 1. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion.
    Marais E, Genade S, Huisamen B, Strijdom JG, Moolman JA, Lochner A.
    J Mol Cell Cardiol; 2001 Apr; 33(4):769-78. PubMed ID: 11273729
    [Abstract] [Full Text] [Related]

  • 2. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
    Marais E, Genade S, Strijdom H, Moolman JA, Lochner A.
    J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA, Hartley S, Van Wyk J, Marais E, Lochner A.
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [Abstract] [Full Text] [Related]

  • 4. CREB activation and ischaemic preconditioning.
    Marais E, Genade S, Lochner A.
    Cardiovasc Drugs Ther; 2008 Feb; 22(1):3-17. PubMed ID: 18205034
    [Abstract] [Full Text] [Related]

  • 5. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
    Fan WJ, van Vuuren D, Genade S, Lochner A.
    Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
    [Abstract] [Full Text] [Related]

  • 6. The temporal relationship between p38 MAPK and HSP27 activation in ischaemic and pharmacological preconditioning.
    Marais E, Genade S, Salie R, Huisamen B, Maritz S, Moolman JA, Lochner A.
    Basic Res Cardiol; 2005 Jan; 100(1):35-47. PubMed ID: 15526116
    [Abstract] [Full Text] [Related]

  • 7. The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical.
    Mocanu MM, Baxter GF, Yue Y, Critz SD, Yellon DM.
    Basic Res Cardiol; 2000 Dec; 95(6):472-8. PubMed ID: 11192368
    [Abstract] [Full Text] [Related]

  • 8. Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK.
    Lochner A, Genade S, Hattingh S, Marais E, Huisamen B, Moolman JA.
    Cardiovasc Drugs Ther; 2003 May; 17(3):217-30. PubMed ID: 14574080
    [Abstract] [Full Text] [Related]

  • 9. Thyroid hormone and cardioprotection: study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart.
    Pantos C, Malliopoulou V, Paizis I, Moraitis P, Mourouzis I, Tzeis S, Karamanoli E, Cokkinos DD, Carageorgiou H, Varonos D, Cokkinos DV.
    Mol Cell Biochem; 2003 Jan; 242(1-2):173-80. PubMed ID: 12619880
    [Abstract] [Full Text] [Related]

  • 10. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.
    Weinbrenner C, Liu GS, Cohen MV, Downey JM.
    J Mol Cell Cardiol; 1997 Sep; 29(9):2383-91. PubMed ID: 9299362
    [Abstract] [Full Text] [Related]

  • 11. Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart.
    Bell JR, Eaton P, Shattock MJ.
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):126-34. PubMed ID: 17892505
    [Abstract] [Full Text] [Related]

  • 12. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.
    Nakano A, Baines CP, Kim SO, Pelech SL, Downey JM, Cohen MV, Critz SD.
    Circ Res; 2000 Feb 04; 86(2):144-51. PubMed ID: 10666409
    [Abstract] [Full Text] [Related]

  • 13. p38 MAPK activity is not increased early during sustained coronary artery occlusion in preconditioned versus control rabbit heart.
    Gysembergh A, Simkhovich BZ, Kloner RA, Przyklenk K.
    J Mol Cell Cardiol; 2001 Apr 04; 33(4):681-90. PubMed ID: 11273721
    [Abstract] [Full Text] [Related]

  • 14. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo.
    Schulz R, Gres P, Skyschally A, Duschin A, Belosjorow S, Konietzka I, Heusch G.
    FASEB J; 2003 Jul 04; 17(10):1355-7. PubMed ID: 12759340
    [Abstract] [Full Text] [Related]

  • 15. Myocardial adenosine does not correlate with the protection mediated by ischaemic or pharmacological preconditioning in rat heart.
    Vasara E, Katharou I, Lazou A.
    Clin Exp Pharmacol Physiol; 2003 Jul 04; 30(5-6):350-6. PubMed ID: 12859425
    [Abstract] [Full Text] [Related]

  • 16. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M, Kaljusto ML, Vaage J, Stensløkken KO.
    Eur J Cardiothorac Surg; 2008 Aug 04; 34(2):344-9. PubMed ID: 18455926
    [Abstract] [Full Text] [Related]

  • 17. Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes.
    Punn A, Mockridge JW, Farooqui S, Marber MS, Heads RJ.
    Biochem J; 2000 Sep 15; 350 Pt 3(Pt 3):891-9. PubMed ID: 10970806
    [Abstract] [Full Text] [Related]

  • 18. The significance of the washout period in preconditioning.
    Salie R, Lochner A, Loubser DJ.
    Cardiovasc Ther; 2017 Jun 15; 35(3):. PubMed ID: 28118517
    [Abstract] [Full Text] [Related]

  • 19. Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.
    Lochner A, Marais E, Genade S, Huisamen B, du Toit EF, Moolman JA.
    Cardiovasc J Afr; 2009 Jun 15; 20(1):43-51. PubMed ID: 19287816
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of p38 MAPK alpha/beta reduces ischemic injury and does not block protective effects of preconditioning.
    Schneider S, Chen W, Hou J, Steenbergen C, Murphy E.
    Am J Physiol Heart Circ Physiol; 2001 Feb 15; 280(2):H499-508. PubMed ID: 11158945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.